Journal article

Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors

Damien Kee, John R Zalcberg

Therapeutic Advances in Medical Oncology | SAGE PUBLICATIONS LTD | Published : 2012


Funding Acknowledgements

JZ: Novartis - honoraria for advisory boards, travel support, research support; Pfizer - honoraria for speaker and grant panel support, research support; Bayer - research support. DK: Bristol Myer-Squibb - honoraria speaker, travel support.